JELMYTO (Mitomycin)

Share Now

Additional Information

Therapeutic class: Chemotherapy  

Chemical class: Mitomycin  

Main indication: JELMYTO® is indicated for the treatment of adult patients with low-grade Upper Tract Urothelial Cancer (LG-UTUC)..

Presentations: 

  • Two 40 mg (each) single-dose vials of mitomycin for 

pyelocalyceal solution

  • One vial of 20 mL sterile hydrogel for reconstitution

Related Products

Disclaimer

Pharma Solution is the marketing agent and Distributor for the listed products for the Gulf and MENA region. The products are either registered and approved by the  respective local health authority or contracted by the MAH to supply to the end users  on a named patient basis. Some products such  as Orphan drugs, rare diseases medicines are imported based on special import permits and as per need of the Hospitals in compliance with full documentation.

[elfsight_whatsapp_chat id='1']